Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2021308162-A1 · Oct 7, 2021 · US
This page is not indexed by search engines while we improve data quality.
Patent family 49380662
This patent family groups 8 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 49380662 |
| Family type | — |
| Earliest priority | Sep 24, 2010 |
| First filing country | US |
| Member publications | 8 |
| Countries | US |
| Representative publication | US2021308162A1 — Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders |
Representative publication
Best representative member for this family based on priority and filing country.
US2021308162A1 — Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders (published Oct 7, 2021)
Member publications
Related publications in this family.
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-10933077-B2 · Mar 2, 2021 · US
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2019374562-A1 · Dec 12, 2019 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-10300083-B2 · May 28, 2019 · US
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2017095493-A1 · Apr 6, 2017 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-9532999-B2 · Jan 3, 2017 · US
Novel tlr4 inhibitors for the treatment of human infectious and inflammatory disorders
US-2015250809-A1 · Sep 10, 2015 · US
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
US-9072760-B2 · Jul 7, 2015 · US